Veru vs TDH
암 및 감염병에 주력하는 임상 단계 바이오테크 기업 vs 애널리스트 커버리지가 제한적인 소형 소비재 기업. 9월 2026에 내 포트폴리오에 더 잘 맞는 종목은 무엇일까요? 아래에서 쉽게 설명합니다.
Veru is a commercial-stage biopharma chasing oncology and infectious disease breakthroughs, while TDH operates as a Chinese aquaculture and seafood business with entirely different growth levers. Both companies trade at micro-cap valuations where sentiment swings can outpace fundamentals, making liquidity and narrative risk central to their stories. Reading Veru vs TDH reveals how two radically different business models can sit in the same speculative tier and what that means for anyone sizing up the risk-reward in each.
Veru is a commercial-stage biopharma chasing oncology and infectious disease breakthroughs, while TDH operates as a Chinese aquaculture and seafood business with entirely different growth levers. Both...
투자 분석
Veru
VERU
장점
- Veru Inc. is a late clinical-stage biopharmaceutical company with a focus on innovative treatments for metabolic diseases, oncology, and viral-related acute respiratory distress syndrome.
- The company’s revenue increased by 3.62% in 2024, showing growth to $16.89 million compared to the previous year.
- Recent capital raising efforts, including a public offering expected to garner approximately $25.2 million gross proceeds, aim to fund key clinical studies and provide working capital.
고려 사항
- Veru Inc. reported significant net losses of $32.71 million trailing twelve months, with an ongoing negative earnings per share of -2.23 making it unprofitable.
- Its market capitalization remains relatively small, around $56.75 million, which can imply higher risk and lower liquidity for investors.
- The stock has shown a wide 52-week price range between $2.64 and $14.20, reflecting high share price volatility and potential investor uncertainty.
TDH
PETZ
장점
- TDH Holdings operates in the commercial real estate management sector in the United States, a stable and tangible asset-based industry.
- The company has a low price-to-book ratio of 0.4x, suggesting possible undervaluation relative to its net asset value.
- With a P/E ratio of 4.8x, TDH Holdings trades at a discount compared to its sector peers, indicating potentially attractive valuation multiples.
고려 사항
- TDH Holdings faces exposure to the US commercial real estate market, which can be cyclical and sensitive to economic downturns or interest rate increases.
- The company’s price-to-sales ratio is elevated at 17.9x, which may imply the stock is priced for high growth that might not materialize.
- There is limited analyst coverage and unclear visibility on growth catalysts or strategic initiatives, increasing uncertainty about future performance.
Nemo에서 VERU 또는 PETZ 매수하기
수수료 무료
주식, ETF 등을 수수료 없이 거래하세요. 수익을 더 많이 지키세요.
신뢰할 수 있는 규제 기관 인가
2015년부터 Exinity Group의 일원으로, 전 세계 100만 명 이상의 고객에게 서비스를 제공합니다.
현금 예치금 6% 이자
투자하지 않은 현금에 연 6%(AER) 이자를 매일 지급합니다.
